Health in Morocco

1,025 indicators covering health for Morocco.

IndicatorLatest Year10-yr change Rank
Tuberculosis treatment success rate in new and relapsed cases 87 2023 down 2.2% 76th
Share of public expenditure on healthcare by country 56.53 2023 up 62.6% 98th
Private health expenditure per person 259.67 2023 down 0.3% 116th
Public healthcare spending share gdp 3.43 2023 up 87.6% 86th
Health spending per person by source 342.62 2023 up 145.5% 118th
Poliomyelitis - number of reported cases 0 2018 β€” 8th
Number of new hiv infections per year 986.63 2024 down 18.5% 78th
Rubella vaccination coverage 98 2024 down 1.0% 22nd
Deaths from aids un 411.61 2024 down 45.4% 65th
Mortality rate among children ages 10 to 14 years 1.07 2020 down 27.7% 122nd
Cost healthy diet 3.54 2024 up 34.6% 147th
Terrorism deaths by region 0 2021 down 100.0% 58th
Medical doctors 29,904 2023 up 74.7% 61st
Adults (ages 15-49) newly infected with HIV 870 2024 down 13.0% 73rd
Number of new hiv child infections vs number of infections averted due 78.76 2024 up 60.8% 51st
Mean systolic blood pressure 124.4 2015 down 1.4% 98th
UHC Service Coverage sub-index on infectious diseases 88 2023 up 8.6% 112th
UHC Service Coverage sub-index on service capacity and access 43 2023 down 12.2% 154th
UHC Service Coverage sub-index on reproductive, maternal, newborn and 73 2023 unchanged 92nd
UHC Service Coverage Index 65 2023 unchanged 128th
UHC Service Coverage sub-index on noncommunicable diseases 63 2023 up 1.6% 100th
Stillbirth rate 12.28 2023 down 17.3% 61st
Number of stillbirths 7,832 2023 down 24.4% 46th
Hepb3 number unvaccinated 18,883 2023 up 175.8% 86th
Rotavirus vaccines completed dose (RotaC) immunization coverage among 92.0% 2025 up 2.2% 25th
Young people (ages 15-24) newly infected with HIV 100 2024 down 50.0% 83rd
Tb related deaths hiv 54 2023 down 50.9% 85th
Smoking bans in public places 5 2022 unchanged 99th
Current health expenditure (CHE) as percentage of gross domestic produ 6.1% 2023 up 15.4% 104th
External health expenditure (EXT) as percentage of current health expe 0.6% 2023 up 93.0% 111th
Domestic general government health expenditure (GGHE-D) as percentage 56.5% 2023 up 62.6% 98th
Out-of-pocket expenditure as percentage of current health expenditure 37.3% 2023 down 27.9% 63rd
Domestic general government health expenditure (GGHE-D) as percentage 3.4% 2023 up 87.6% 88th
Domestic general government health expenditure (GGHE-D) as percentage 10.6% 2023 up 76.6% 89th
Domestic private health expenditure (PVT-D) as percentage of current h 42.8% 2023 down 34.0% 76th
Current health expenditure (CHE) per capita in US$ 232.25 2023 up 29.2% 127th
Domestic private health expenditure (PVT-D) per capita in US$ 99.51 2023 down 14.7% 114th
Domestic general government health expenditure (GGHE-D) per capita in 131.3 2023 up 110.0% 118th
Total healthcare expenditure gdp 6.06 2023 up 15.4% 104th
Health expenditure government expenditure 10.61 2023 up 76.6% 90th
Incidence of tuberculosis (per 100 000 population) 1.1 2023 down 35.3% 101st
Hib vaccine 96 2024 down 3.0% 47th
External health expenditure (EXT) per capita in US$ 1.44 2023 up 149.3% 121st
Dentists 492 2024 down 89.4% 106th
Nursing and midwifery personnel 27,406 2024 down 15.1% 85th
Nursing personnel 20,834 2024 down 29.6% 94th
People using safely managed drinking water services, rural 58.4% 2024 up 93.8% 29th
Raised blood pressure (SBP>=140 OR DBP>=90) 31.75 2019 down 7.2% 95th
Raised blood pressure (SBP>=140 OR DBP>=90) 31.58 2019 down 3.6% 81st
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 43.0% 2019 up 11.4% 148th
Hypertension among adults aged 30-79 years, prevalence, age-standardiz 35.3 2019 down 5.4% 120th
Hypertension effective treatment coverage (controlled hypertension )am 10.1% 2019 up 23.2% 153rd
Hypertension: effective treatment coverage (controlled hypertension) a 10.1% 2019 up 26.2% 151st
Hypertension treatment coverage among adults aged 30-79 with hypertens 28.7% 2019 up 10.0% 137th
Hypertension treatment coverage among adults aged 30-79 with hypertens 28.8% 2019 up 6.3% 140th
Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 42.9% 2019 up 14.1% 140th
Hypertension among adults aged 30-79 years, prevalence, crude 35.1 2019 down 1.4% 117th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati 77.0% 2025 down 18.9% 124th
Adolescent birth rate 0.0121 2018 down 95.3% 137th
Rubella number unvaccinated 12,588 2023 up 86.4% 72nd